Cargando…
COVID-19 vaccines: A perspective from social pharmacology
Social pharmacology is a branch of clinical pharmacology, which depicts relationships between society and drugs and in particular factors, reasons, social consequences of drug use as well as representations of drugs in the society. Recent development and marketing of coronavirus disease 2019 (COVID-...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161798/ https://www.ncbi.nlm.nih.gov/pubmed/34119317 http://dx.doi.org/10.1016/j.therap.2021.05.010 |
_version_ | 1783700578513190912 |
---|---|
author | Montastruc, Jean-Louis Lafaurie, Margaux de Canecaude, Claire Montastruc, François Bagheri, Haleh Durrieu, Geneviève Sommet, Agnès |
author_facet | Montastruc, Jean-Louis Lafaurie, Margaux de Canecaude, Claire Montastruc, François Bagheri, Haleh Durrieu, Geneviève Sommet, Agnès |
author_sort | Montastruc, Jean-Louis |
collection | PubMed |
description | Social pharmacology is a branch of clinical pharmacology, which depicts relationships between society and drugs and in particular factors, reasons, social consequences of drug use as well as representations of drugs in the society. Recent development and marketing of coronavirus disease 2019 (COVID-19) vaccines raises a number of questions of social pharmacology: are vaccines drugs like any other? What is their perception at the individual, population and societal levels? How do individuals perceive the risks and benefits of these vaccines? What is the perception at the societal level? What is the individual and societal acceptability of these vaccines during a pandemic? All these questions are discussed in the light of recent data. A number of proposals, both at the individual and at the collective or population level, are formulated to help solve these problems of social pharmacology. |
format | Online Article Text |
id | pubmed-8161798 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81617982021-05-28 COVID-19 vaccines: A perspective from social pharmacology Montastruc, Jean-Louis Lafaurie, Margaux de Canecaude, Claire Montastruc, François Bagheri, Haleh Durrieu, Geneviève Sommet, Agnès Therapie COVID-19/Social pharmacology Social pharmacology is a branch of clinical pharmacology, which depicts relationships between society and drugs and in particular factors, reasons, social consequences of drug use as well as representations of drugs in the society. Recent development and marketing of coronavirus disease 2019 (COVID-19) vaccines raises a number of questions of social pharmacology: are vaccines drugs like any other? What is their perception at the individual, population and societal levels? How do individuals perceive the risks and benefits of these vaccines? What is the perception at the societal level? What is the individual and societal acceptability of these vaccines during a pandemic? All these questions are discussed in the light of recent data. A number of proposals, both at the individual and at the collective or population level, are formulated to help solve these problems of social pharmacology. Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. 2021 2021-05-28 /pmc/articles/PMC8161798/ /pubmed/34119317 http://dx.doi.org/10.1016/j.therap.2021.05.010 Text en © 2021 Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | COVID-19/Social pharmacology Montastruc, Jean-Louis Lafaurie, Margaux de Canecaude, Claire Montastruc, François Bagheri, Haleh Durrieu, Geneviève Sommet, Agnès COVID-19 vaccines: A perspective from social pharmacology |
title | COVID-19 vaccines: A perspective from social pharmacology |
title_full | COVID-19 vaccines: A perspective from social pharmacology |
title_fullStr | COVID-19 vaccines: A perspective from social pharmacology |
title_full_unstemmed | COVID-19 vaccines: A perspective from social pharmacology |
title_short | COVID-19 vaccines: A perspective from social pharmacology |
title_sort | covid-19 vaccines: a perspective from social pharmacology |
topic | COVID-19/Social pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161798/ https://www.ncbi.nlm.nih.gov/pubmed/34119317 http://dx.doi.org/10.1016/j.therap.2021.05.010 |
work_keys_str_mv | AT montastrucjeanlouis covid19vaccinesaperspectivefromsocialpharmacology AT lafauriemargaux covid19vaccinesaperspectivefromsocialpharmacology AT decanecaudeclaire covid19vaccinesaperspectivefromsocialpharmacology AT montastrucfrancois covid19vaccinesaperspectivefromsocialpharmacology AT bagherihaleh covid19vaccinesaperspectivefromsocialpharmacology AT durrieugenevieve covid19vaccinesaperspectivefromsocialpharmacology AT sommetagnes covid19vaccinesaperspectivefromsocialpharmacology |